Rinat Neuroscience had an experimental drug that sharply reduced appetite in rodents.

In 2007 Rinat Akhmetov, a Ukrainian tycoon, went to a London court to Sue a Ukraine-based website about an article published only in ukrainian-though read in britain-and won.

The surprising result prompted Pfizer, which acquired Rinat, to explore whether the drug instead could promote weight gain, perhaps for cancer patients or others suffering from wasting.